Improving Regulatory Transparency for New Medical Therapies Act

Pub. L. 114–89

10 sections of the Code credited to this law, found between Public Law 114-86u1 and Public Law 114-93, except 92.

• 21 U.S.C. § 355 — New drugs
• 21 U.S.C. § 360b — New animal drugs
• 21 U.S.C. § 360ccc — Conditional approval of new animal drugs for minor use and minor species
• 21 U.S.C. § 360ccc–1 — Index of legally marketed unapproved new animal drugs for minor species
• 21 U.S.C. § 360ccc–2 — Designated new animal drugs for minor use or minor species
• 21 U.S.C. § 811 — Authority and criteria for classification of substances
• 21 U.S.C. § 823 — Registration requirements
• 21 U.S.C. § 953 — Exportation of controlled substances
• 35 U.S.C. § 156 — Extension of patent term
• 42 U.S.C. § 262 — Regulation of biological products